← Open Payments lookup

DANIEL RING: Open Payments

NPI 1669987012 · CABOT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$525 in 28 payments from 13 companies in 2025. Trend: 2023 $2,219 · 2024 $2,173 · 2025 $525

Food & beverage: $525
CompanyPaymentsAmount
PFIZER INC.6$94
ABBVIE INC.4$90
Phathom Pharmaceuticals, Inc.5$79
Janssen Biotech, Inc.2$49
AstraZeneca Pharmaceuticals LP2$34
Novo Nordisk Inc2$30
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Antares Pharma, Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22

Products named: XELJANZ, VOQUEZNA, VRAYLAR, TREMFYA, UBRELVY, JARDIANCE, XIFAXAN, XYOSTED.

Industry payments across AR — which companies pay providers there.